CB1 blockade with rimonabant: a new therapeutic approach for the management of patients at high cardiometabolic risk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)20-ev
JournalNetherlands heart journal
Volume14
Issue numberSuppl. 2
Publication statusPublished - 2006

Cite this